nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—MAOA—attention deficit hyperactivity disorder	0.237	0.298	CbGaD
Pseudoephedrine—SLC6A3—attention deficit hyperactivity disorder	0.205	0.257	CbGaD
Pseudoephedrine—ADRA2A—attention deficit hyperactivity disorder	0.201	0.252	CbGaD
Pseudoephedrine—SLC6A4—attention deficit hyperactivity disorder	0.153	0.192	CbGaD
Pseudoephedrine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00761	0.113	CbGeAlD
Pseudoephedrine—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.00701	0.104	CbGeAlD
Pseudoephedrine—NFATC1—cardiovascular system—attention deficit hyperactivity disorder	0.00409	0.0605	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00404	0.0599	CbGeAlD
Pseudoephedrine—IL2—cardiovascular system—attention deficit hyperactivity disorder	0.00374	0.0553	CbGeAlD
Pseudoephedrine—NFATC1—nervous system—attention deficit hyperactivity disorder	0.00262	0.0388	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—attention deficit hyperactivity disorder	0.00253	0.0374	CbGeAlD
Pseudoephedrine—NFATC1—cerebellum—attention deficit hyperactivity disorder	0.00247	0.0366	CbGeAlD
Pseudoephedrine—IL2—nervous system—attention deficit hyperactivity disorder	0.0024	0.0355	CbGeAlD
Pseudoephedrine—IL2—central nervous system—attention deficit hyperactivity disorder	0.00231	0.0342	CbGeAlD
Pseudoephedrine—NFATC1—brain—attention deficit hyperactivity disorder	0.00201	0.0297	CbGeAlD
Pseudoephedrine—IL2—brain—attention deficit hyperactivity disorder	0.00183	0.0272	CbGeAlD
Pseudoephedrine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00117	0.0173	CbGeAlD
Pseudoephedrine—ADRB1—forebrain—attention deficit hyperactivity disorder	0.00111	0.0164	CbGeAlD
Pseudoephedrine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00107	0.0158	CbGeAlD
Pseudoephedrine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.000942	0.0139	CbGeAlD
Pseudoephedrine—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000937	0.0139	CbGeAlD
Pseudoephedrine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000876	0.013	CbGeAlD
Pseudoephedrine—MAOA—forebrain—attention deficit hyperactivity disorder	0.000868	0.0129	CbGeAlD
Pseudoephedrine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.000771	0.0114	CbGeAlD
Pseudoephedrine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000741	0.011	CbGeAlD
Pseudoephedrine—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.000734	0.0109	CbGeAlD
Pseudoephedrine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000707	0.0105	CbGeAlD
Pseudoephedrine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000666	0.00986	CbGeAlD
Pseudoephedrine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000634	0.00939	CbGeAlD
Pseudoephedrine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.00061	0.00904	CbGeAlD
Pseudoephedrine—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000601	0.0089	CbGeAlD
Pseudoephedrine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000597	0.00883	CbGeAlD
Pseudoephedrine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000581	0.0086	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.000579	0.00857	CbGeAlD
Pseudoephedrine—MAOA—midbrain—attention deficit hyperactivity disorder	0.000573	0.00849	CbGeAlD
Pseudoephedrine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000559	0.00828	CbGeAlD
Pseudoephedrine—Methamphetamine—ADRA2C—attention deficit hyperactivity disorder	0.000533	0.0891	CrCbGaD
Pseudoephedrine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000516	0.00764	CbGeAlD
Pseudoephedrine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000512	0.00757	CbGeAlD
Pseudoephedrine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000493	0.00729	CbGeAlD
Pseudoephedrine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000485	0.00717	CbGeAlD
Pseudoephedrine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000476	0.00704	CbGeAlD
Pseudoephedrine—MAOA—nervous system—attention deficit hyperactivity disorder	0.000471	0.00698	CbGeAlD
Pseudoephedrine—ADRB1—brain—attention deficit hyperactivity disorder	0.00046	0.00681	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000458	0.00678	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000454	0.00672	CbGeAlD
Pseudoephedrine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000448	0.00662	CbGeAlD
Pseudoephedrine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000444	0.00657	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—attention deficit hyperactivity disorder	0.000444	0.00657	CbGeAlD
Pseudoephedrine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.00044	0.00651	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—MAOA—attention deficit hyperactivity disorder	0.000424	0.0708	CrCbGaD
Pseudoephedrine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000391	0.00579	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—DRD1—attention deficit hyperactivity disorder	0.000386	0.0644	CrCbGaD
Pseudoephedrine—Phentermine—MAOA—attention deficit hyperactivity disorder	0.000378	0.0631	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—SLC6A3—attention deficit hyperactivity disorder	0.000366	0.0611	CrCbGaD
Pseudoephedrine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000364	0.00538	CbGeAlD
Pseudoephedrine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000362	0.00535	CbGeAlD
Pseudoephedrine—MAOA—brain—attention deficit hyperactivity disorder	0.00036	0.00533	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—ADRA2A—attention deficit hyperactivity disorder	0.000358	0.0599	CrCbGaD
Pseudoephedrine—Selegiline—MAOA—attention deficit hyperactivity disorder	0.00035	0.0584	CrCbGaD
Pseudoephedrine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000348	0.00515	CbGeAlD
Pseudoephedrine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.00034	0.00504	CbGeAlD
Pseudoephedrine—Phentermine—SLC6A3—attention deficit hyperactivity disorder	0.000326	0.0544	CrCbGaD
Pseudoephedrine—Dextroamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000311	0.0519	CrCbGaD
Pseudoephedrine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00028	0.00415	CbGeAlD
Pseudoephedrine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000276	0.00409	CbGeAlD
Pseudoephedrine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00027	0.00399	CbGeAlD
Pseudoephedrine—Methamphetamine—MAOA—attention deficit hyperactivity disorder	0.000269	0.045	CrCbGaD
Pseudoephedrine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000264	0.0039	CbGeAlD
Pseudoephedrine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.000253	0.0423	CrCbGaD
Pseudoephedrine—Amphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000251	0.0419	CrCbGaD
Pseudoephedrine—Phentermine—SLC6A4—attention deficit hyperactivity disorder	0.000244	0.0407	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000232	0.0388	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.000229	0.0382	CrCbGaD
Pseudoephedrine—Methamphetamine—ADRA2A—attention deficit hyperactivity disorder	0.000228	0.038	CrCbGaD
Pseudoephedrine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000214	0.00317	CbGeAlD
Pseudoephedrine—Amphetamine—SLC6A4—attention deficit hyperactivity disorder	0.000187	0.0313	CrCbGaD
Pseudoephedrine—Amphetamine—DRD2—attention deficit hyperactivity disorder	0.000186	0.0311	CrCbGaD
Pseudoephedrine—Methamphetamine—SLC6A4—attention deficit hyperactivity disorder	0.000174	0.029	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.000171	0.0285	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.000131	0.0219	CrCbGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	6.33e-05	0.000484	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	6.31e-05	0.000482	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	6.28e-05	0.00048	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.23e-05	0.000475	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.22e-05	0.000475	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	6.12e-05	0.000467	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.12e-05	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	6.11e-05	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	6.1e-05	0.000466	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.05e-05	0.000462	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.04e-05	0.000462	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	5.98e-05	0.000457	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	5.98e-05	0.000456	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	5.92e-05	0.000452	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	5.87e-05	0.000448	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.85e-05	0.000447	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	5.79e-05	0.000442	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.76e-05	0.00044	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.76e-05	0.00044	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	5.69e-05	0.000435	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	5.68e-05	0.000434	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.65e-05	0.000431	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.65e-05	0.000431	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.64e-05	0.000431	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.63e-05	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.63e-05	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	5.62e-05	0.000429	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	5.6e-05	0.000428	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	5.56e-05	0.000424	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EP300—attention deficit hyperactivity disorder	5.55e-05	0.000424	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	5.54e-05	0.000423	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.52e-05	0.000422	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.5e-05	0.00042	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.45e-05	0.000416	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.44e-05	0.000415	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	5.38e-05	0.000411	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.36e-05	0.000409	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.33e-05	0.000407	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.29e-05	0.000404	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.29e-05	0.000404	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.27e-05	0.000402	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.24e-05	0.0004	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	5.24e-05	0.0004	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.23e-05	0.0004	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	5.22e-05	0.000399	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—EP300—attention deficit hyperactivity disorder	5.21e-05	0.000398	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	5.21e-05	0.000398	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.18e-05	0.000395	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	5.18e-05	0.000395	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.18e-05	0.000395	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.13e-05	0.000392	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.12e-05	0.000391	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.11e-05	0.00039	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.02e-05	0.000383	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.97e-05	0.00038	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	4.95e-05	0.000378	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.93e-05	0.000376	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	4.9e-05	0.000374	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	4.87e-05	0.000372	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.82e-05	0.000368	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.76e-05	0.000364	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.72e-05	0.00036	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.7e-05	0.000359	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	4.66e-05	0.000356	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.61e-05	0.000352	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.58e-05	0.00035	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	4.57e-05	0.000349	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	4.55e-05	0.000348	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	4.55e-05	0.000348	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.53e-05	0.000346	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.51e-05	0.000344	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.43e-05	0.000339	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.43e-05	0.000338	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.41e-05	0.000337	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.4e-05	0.000336	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.37e-05	0.000334	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	4.33e-05	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	4.33e-05	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	4.28e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.28e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	4.24e-05	0.000324	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.23e-05	0.000323	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	4.23e-05	0.000323	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	4.23e-05	0.000323	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.16e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.15e-05	0.000317	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.1e-05	0.000313	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	3.99e-05	0.000305	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	3.98e-05	0.000304	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	3.98e-05	0.000304	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.94e-05	0.000301	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	3.93e-05	0.0003	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.91e-05	0.000299	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	3.85e-05	0.000294	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.83e-05	0.000292	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.73e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	3.71e-05	0.000283	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.67e-05	0.00028	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.6e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.55e-05	0.000271	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.52e-05	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.48e-05	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.47e-05	0.000265	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.45e-05	0.000264	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.42e-05	0.000261	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.41e-05	0.00026	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.38e-05	0.000258	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.35e-05	0.000256	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.34e-05	0.000255	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EP300—attention deficit hyperactivity disorder	3.23e-05	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.18e-05	0.000243	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.17e-05	0.000242	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.11e-05	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.11e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.09e-05	0.000236	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.08e-05	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.04e-05	0.000232	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.03e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.03e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.02e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.01e-05	0.00023	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.99e-05	0.000228	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EP300—attention deficit hyperactivity disorder	2.98e-05	0.000228	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.97e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.96e-05	0.000226	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.96e-05	0.000226	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.94e-05	0.000225	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.92e-05	0.000223	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.91e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.91e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.89e-05	0.000221	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.88e-05	0.00022	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	2.87e-05	0.000219	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.87e-05	0.000219	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	2.83e-05	0.000216	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.82e-05	0.000216	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.8e-05	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.79e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.79e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.78e-05	0.000212	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.77e-05	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.75e-05	0.00021	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.74e-05	0.000209	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EP300—attention deficit hyperactivity disorder	2.73e-05	0.000209	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.72e-05	0.000208	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.72e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.71e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.69e-05	0.000205	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.67e-05	0.000204	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.66e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.63e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.6e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.57e-05	0.000197	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.57e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.53e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.51e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.5e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.49e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.47e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.45e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.45e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.42e-05	0.000185	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.4e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.39e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.34e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.34e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.32e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.32e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.3e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.28e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.26e-05	0.000173	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.25e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.25e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.23e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.22e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.2e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.19e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.17e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.1e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.1e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.09e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.09e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.05e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.05e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.04e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EP300—attention deficit hyperactivity disorder	1.98e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.95e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.92e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.92e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.91e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.9e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.89e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.84e-05	0.00014	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.81e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.8e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.77e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.77e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.75e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	1.74e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.73e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.71e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.7e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.67e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.65e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.62e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.62e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.6e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.59e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.58e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.58e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.57e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.53e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.49e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.48e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.47e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.46e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.43e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.38e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.38e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.34e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.33e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.3e-05	9.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.28e-05	9.79e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.25e-05	9.55e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.25e-05	9.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.24e-05	9.49e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.23e-05	9.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.23e-05	9.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.21e-05	9.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.21e-05	9.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.16e-05	8.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.15e-05	8.81e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.14e-05	8.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.12e-05	8.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.05e-05	7.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.02e-05	7.82e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.99e-06	7.63e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.51e-06	7.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.47e-06	6.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.87e-06	6.01e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	7.57e-06	5.78e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.52e-06	5.74e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	7.46e-06	5.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.54e-06	4.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.42e-06	4.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	4.98e-06	3.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.49e-06	3.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.17e-06	3.18e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.25e-06	2.48e-05	CbGpPWpGaD
